La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Modèle »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Modulation amplitude < Modèle < Modèle animal  Facettes :

List of bibliographic references indexed by Modèle

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000B91 (2014) C. H. Carriere [Canada] ; N. H. Kang [Canada] ; L. P. Niles [Canada]NEUROPROTECTION BY VALPROIC ACID IN AN INTRASTRIATAL ROTENONE MODEL OF PARKINSON'S DISEASE
001488 (2012) Alexander Klein [Royaume-Uni] ; Lori-Ann R. Sacrey [Canada] ; Ian Q. Whishaw [Canada] ; Stephen B. Dunnett [Royaume-Uni]The use of rodent skilled reaching as a translational model for investigating brain damage and disease
001503 (2012) Anthony N. Carlsen [Canada] ; Dana Maslovat [Canada] ; Ian M. Franks [Canada]Preparation for voluntary movement in healthy and clinical populations: Evidence from startle : Neurophysiology of the Brainstem
001778 (2011) James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
001967 (2011) Matthias Kliegel [Allemagne] ; Mareike Altgassen [Allemagne] ; Alexandra Hering [Allemagne] ; Nathan S. Rose [Canada]A process-model based approach to prospective memory impairment in Parkinson's disease
001C36 (2010) Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease
001C85 (2010) Robert A. Hodgson [États-Unis] ; Paul J. Bedard [Canada] ; Geoffrey B. Varty [États-Unis] ; Tatiana M. Kazdoba [États-Unis] ; Therese Di Paolo [Canada] ; Michael E. Grzelak [États-Unis] ; Annamarie J. Pond [États-Unis] ; Abdallah Hadjtahar [Canada] ; Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; Aurelie Dare [Canada] ; Bernard R. Neustadt [États-Unis] ; Andrew W. Stamford [États-Unis] ; John C. Hunter [États-Unis]Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
001C94 (2010) Jae H. T. Lee [Canada] ; Seth Tigchelaar [Canada] ; JIE LIU [Canada] ; Anthea M. T. Stammers [Canada] ; Femke Streijger [Canada] ; Wolfram Tetzlaff [Canada] ; Brian K. Kwon [Canada]Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury
001F19 (2009) Katerina Venderova ; Ghassan Kabbach ; Elizabeth Abdel-Messih ; Yi Zhang ; Robin J. Parks ; Yuzuru Imai ; Stephan Gehrke ; Johnny Ngsee ; Matthew J. Lavoie ; Ruth S. Slack ; Yong Rao [Canada] ; Zhuohua Zhang [États-Unis] ; Bingwei Lu ; M. Emdadul Haque [Canada] ; David S. Park [Canada]Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
002373 (2008) Naomi P. Visanji [Canada] ; Rob M. A. De Bie [Canada] ; Tom H. Johnston [Canada] ; Andrew C. Mccreary [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]The Nociceptin/Orphanin FQ (NOP) Receptor Antagonist J-113397 Enhances the Effects of Levodopa in the MPTP-Lesioned Nonhuman Primate Model of Parkinson's Disease
002528 (2007) Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada]Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia
002553 (2007) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Lennard P. Niles [Canada]Neural stem cell transplantation and melatonin treatment in a 6‐hydroxydopamine model of Parkinson’s disease
002668 (2007) J. M. B. Wilson [Canada] ; C. A. Shaw [Canada]Late appearance of glutamate transporter defects in a murine model of ALS-parkinsonism dementia complex
002673 (2007) A. Y. Alemdar [Canada] ; D. Sadi [Canada] ; V. Mcalister [Canada] ; I. Mendez [Canada]Intracerebral Co-transplantation of liposomal tacrolimus improves xenograft survival and reduces graft rejection in the hemiparkinsonian rat
002693 (2007) Joseph Flores [Canada] ; Ivan L. Cepeda [Canada] ; Michael L. Comfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada]Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of parkinson disease
002915 (2006) Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada]Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
002925 (2006) Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease
002A96 (2005) Monty A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Canada]Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of parkinson's disease
002D16 (2004) D. J. Doudet [Canada] ; M. L. Cornfeldt [États-Unis] ; C. R. Honey [Canada] ; A. W. Schweikert [États-Unis] ; R. C. Allen [États-Unis]PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of parkinson's disease
002F19 (2003) Jackalina Van Kampen [Canada] ; Harold Robertson [Canada] ; Theo Hagg [Canada] ; Robert Drobitch [Canada]Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease
003327 (2001) A. R. Zahran [Canada] ; N. Simmerman [Canada] ; S. Carrier [Canada] ; P. Vachon [Canada] ; Y. SatoErectile dysfunction occurs following substantia nigra lesions in the rat. Commentary

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Modèle" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Modèle" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Modèle
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022